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negatively on patients' quality of life. Specialist podiatrists have a prime role to play in the assessment and
management of foot and ankle problems within this patient group. However, it has been identiﬁed that in many
areas there is no specialist podiatry service, with many patients being managed by non‐specialist podiatrists.
Therefore, the North West Clinical Effectiveness Group for the Foot in Rheumatic Diseases (NWCEG) identiﬁed
the need to develop ‘practitioner facing’ guidelines for the management of speciﬁc foot health problems associated
with RA.
Methods. Members of a guideline development group from the NWCEG each reviewed the evidence for speciﬁc
aspects of the assessment and management of foot problems. Where evidence was lacking, ‘expert opinion’ was
obtained from the members of the NWCEG and added as a consensus on current and best practice. An iterative
approach was employed, with the results being reviewed and revised by all members of the group and external
reviewers before the ﬁnal guideline document was produced.
Results. The management of speciﬁc foot problems (callus, nail pathology, ulceration) and the use of speciﬁc
interventions (foot orthoses, footwear, patient education, steroid injection therapy) are detailed and standards in
relation to each are provided. A diagrammatic screening pathway is presented, with the aim of guiding non‐
specialist podiatrists through the complexity of assessing and managing those patients with problems requiring
input from a specialist podiatrist and other members of the rheumatology multidisciplinary team.
Conclusion. This pragmatic approach ensured that the guidelines were relevant and applicable to current practice
as ‘best practice’, based on the available evidence from the literature and consensus expert opinion. These
guidelines provide both specialist and non‐specialist podiatrists with the essential and ‘gold standard’ aspects of
managing people with RA‐related foot problems. Copyright © 2011 John Wiley & Sons, Ltd.
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Guidelines for RA‐Related Foot Problems Williams et al.Introduction trained to carry out speciﬁc care or treatment, orRheumatoid arthritis (RA) is a chronic systemic disease
that commonly affects the feet (Grondal et al., 2008),
and as Shi et al. (2000) identiﬁed, virtually 100% of
patients report foot problems within 10 years of disease
onset. The structural and functional changes in the feet
often affect gait and mobility (Turner et al., 2006;
Woodburn et al., 2002a; Turner et al., 2006), impacting
negatively on the patient's quality of life (Otter et al.,
2010; Wickman et al., 2004) and speciﬁcally restricting
the choice of footwear (Goodacre and Candy, 2010;
Williams et al., 2007, 2010). For some people with RA,
the structural changes are a factor in foot ulcer
development (Firth et al., 2008), with the risk of
infection, particularly if the patient's medical manage-
ment includes the use of immunosuppressive drugs
(Otter et al., 2004; Wilske, 1993).
The speciﬁc goals of foot care for the problems
associated with RA are to relieve pain, maintain
function and prevent ulceration and infection, thereby
contributing positively to the patient's quality of life
(Woodburn and Helliwell, 1997). These goals can be
achieved with the use of foot health interventions such
as care of the skin and nails, foot orthoses and specialist
‘therapeutic’ footwear. The use of foot orthoses and
therapeutic footwear are supported by national guide-
lines (Arthritis and Musculoskeletal Alliance [ARMA],
2004; National Institute for Clinical Excellence [NICE],
2009), which also recommend that people with RA
should have access to foot health assessment and
management early in the disease process. Foot health
providers, such as podiatrists, have a prime role to play
in the assessment and management of foot and ankle
problems within this patient group (NICE, 2009). This
view is supported by the Podiatry Rheumatic Care
Association (PRCA) Standards of Care, ARMA (2004)
and the British Society for Rheumatology (BSR)
(Luqmani et al., 2006). They all strongly advocate the
need for a dedicated and specialist podiatry service for
the diagnosis, assessment and management of foot
problems associated with RA, along with periodic review,
particularly for those patients with high levels of disease
activity. The PRCA (2010) guidelines state that:‘People whose condition does not respond to
treatment, who experience new or worsening
symptoms, or whose personal situations change,
should have timely access to health professionalswho can refer them to other specialist care if needed.
Foot health service providers should be aware of
indications for urgent referrals, surgical referrals
and disease red ﬂags.’ (Standard 22, page 22)
Despite evidence for the need of podiatry services
(Williams and Bowden, 2004) and efforts to ensure that
the recommendations made by NICE (2009) and the
PRCA Standards of Care are met, there are identiﬁed
problems with access to podiatry services. The problems
identiﬁed in both the National Audit Ofﬁce report
(2009) and the Rheumatology Futures Group report
(2009) was that podiatry was an underused and under‐
resourced service and that in many areas there was no
specialist podiatry service. Limited services were also
identiﬁed by Juarez et al. (2010), who found that in one
district hospital, less than one‐third of RA patients had
access to specialist care. An earlier review of the
provision of foot health services in rheumatology
departments in the UK (Redmond et al., 2006) found
that only 50% reported adequate basic foot care services
and less than one in 10 had formal care pathways or
mechanisms for referral. Interestingly, a fair proportion
of RA patients access foot care through non‐specialist
routes. Williams and Bowden (2004) identiﬁed that
19% of the 139 patients surveyed accessed foot care
through the private sector and 21% were receiving foot
care at local NHS clinics by non‐specialist podiatrists.
In support of specialist foot care, the PRCA Standards
of Care are ‘patient facing’ in respect of the service that
patients with foot problems can expect. However, due to
the lack of specialist podiatry provision for RA patients,
there is a need for ‘practitioner facing’ management
guidelines, to provide non‐specialist podiatrists and
other foot health providers with speciﬁc guidance for
the management of people with RA‐related foot health
problems. Our aims, therefore, were to develop
‘practitioner facing’ guidelines on the management of
speciﬁc foot health problems associated with RA using
an evidence‐based approach and consensus of specialist
podiatrist practitioners.Methods
Guideline development
A guideline development group was formed from
members of the North West Clinical EffectivenessMusculoskelet. Care (2011) © 2011 John Wiley & Sons, Ltd.
Williams et al. Guidelines for RA‐Related Foot ProblemsGroup (NWCEG). The group included the Chair of
the NWCEG (S.D.), the academic lead for the group
(A.W.), two academics with a podiatry background
(A.G. and C.B.) and three specialist podiatrists (K.L.,
A.B. and C.L.). Each member of the group took
responsibility for speciﬁc aspects of management of the
foot affected by RA: the management of callus,
management of nail conditions, management of
ulceration, foot orthoses and footwear, steroid injec-
tion therapy, surgery, ultrasonography and patient
education.
All relevant available databases were searched (from
2000 to 2010), speciﬁcally Medline, Embase, the
Cochrane Database and the Cochrane Musculoskeletal
Group Register. References from all articles identiﬁed
from the databases were also hand searched. The terms
‘rheumatoid arthritis’ and ‘foot’ were combined and
searched in conjunction with the following treatment
terms: ‘treatment’, ‘management’, ‘services’, ‘guide-
lines’, ‘standards of care’, ‘surgery’, ‘ultrasound’,
‘injection therapy’, ‘orthoses’, ‘footwear’, ‘callus’, ‘foot
ulcers’ and ‘patient education’.
The evidence was used to inform each section of the
initial draft of the guidelines. These were then taken to
the NWCEG for review; where evidence was lacking,
expert opinion was obtained and added to each section
of the guidelines as a consensus of current best practice.
Each section was then further developed and edited by
one member of the guideline group (A.W.) to ensure
consistency in presentation and content. This formed
the second draft of the guidelines, which were sent to
three external reviewers, two consultant rheumatolo-
gists and the Chair of the Podiatry Rheumatic Care
Association. Following feedback from the external
reviewers, the ﬁnal guideline document was produced.
Results
Guideline summary
The achievement of the group was that a consensus
was agreed for all aspects of management for people
with RA‐related foot pathology, based on available
evidence and best practice. The guidelines compre-
hensively cover all aspects of current foot health
management in relation to the requirements of a
service, referral pathways, management of speciﬁc
conditions and the evaluation of interventions.
The philosophy of podiatry services for people with
RA is to relieve pain, maintain function and mobility,Musculoskelet. Care (2011) © 2011 John Wiley & Sons, Ltd.prevent or minimize deformity and reduce the risk of
ulceration, thereby maintaining or improving the
individuals' independence and overall quality of life.
Aligned with this philosophy is the fact that podiatrists
are ideally placed to alert other members of the
multidisciplinary team (MDT) if the patient's health
status deteriorates or if other, profession‐speciﬁc,
interventions are needed, such as physiotherapy or
occupational therapy.
The guidelines contain speciﬁc reference to the role
of the clinical specialist and both the essential and
‘gold standard’ requirements for a podiatry service.
The rationale for identifying both the essential and
gold standard requirements is to contextualize the
importance of foot care for this patient group, while
acknowledging that some services are restricted in
relation to advanced resources, such as ultrasonogra-
phy or steroid injection therapy. Further, podiatry
services that are developing in relation to the
management of people with RA need guidance as to
the ideal, ‘gold standard’ resources that could be added
as funding becomes available.
The guidelines recommend that a local pathway of
referral should be in place to facilitate appropriate and
timely patient referrals to a specialist podiatrist by any
member of the podiatry team, the rheumatology MDT,
primary care team or private practitioner. In the absence
of a specialist podiatrist, there is guidance for referral to
other members of the rheumatology MDT, so that
patients with complex foot problems, such as ulcera-
tion, receive the right management in relation to their
foot and general disease management (see Figure 1).
The aims of the foot screening pathway and a
primary assessment/annual screening tool (an example
of which is in the full guideline document) are to
enable identiﬁcation of those patients who are at risk of
ulceration or the development of deformity, and to
initiate appropriate and timely interventions. In
addition, it is recommended that practitioners working
in the private sector make links with local specialist
podiatry services or rheumatology services in order to
facilitate timely referral for patients whose foot health
deteriorates.
A thorough primary assessment, followed by an
annual review, is essential in managing patients' foot
health with the aim of identifying changes in foot
health and monitoring foot health interventions.
Despite individual podiatry services having different
arrangements for new and existing patients in both
Foot Screening Pathway for People with RA  
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YES NOFOOT HEALTH EDUCATION ANNUAL REVIEW WITH PODIATRIST
FOOT HEALTH  ASSESSMENT
SKIN
Ulceration (NB 
cellulitis may be 
minimal –
indicator of 
infection may be 
pain) 
Requirement for 
antibiotics, 
radiographs
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Evidence of 
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with joints/
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FUNCTION 
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pronation
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stability
Falls
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muscle 
strength
Poor 
posture
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range of 
motion 
Increasing 
stiffness
LIFESTYLE
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lifestyle 
habits e.g. 
smoking
Poor diet
Weight loss
ACTIVITIES 
OF DAILY 
LIVING
Increasing 
difficulty 
with 
everyday 
tasks
Difficulty 
coping with 
fatigue
NAILS
Evidence of 
bacterial 
infection (need 
for antibiotics 
and/or advise  
if patient is on 
biologic 
therapy)
Need for nail 
surgery
Evidence of 
fungal 
infection
(diagnosed 
from mycology 
results
RHEUMATOLOGY 
SPECIALIST NURSE
RHEUMATOLOGIST
SPECIALIST PODIATRIST
ORTHOTIST
PHYSIOTHERAPIST OCCUPATIONAL 
THERAPIST 
DIETICIAN
SMOKING 
CESSATION
SURGICAL OPINION
NB   IN THE ABSENCE OF A SPECIALIST PODIATRIST -
• ADVICE SHOULD BE OBTAINED FROM THE PATIENT’S CONSULTANT AS DENOTED BY A RED LINE
• ADVICE SHOULD BE OBTAINED FROM AN ORTHOTIST AS DENOTED BY A BLUE LINE
• BLACK LINES DENOTE DIRECT REFERRAL
• GREEN LINES DENOTE MULTIDISCIPLINARY WORKING BETWEEN THE CORE RHEUMATOLOGY MULTIDISCIPLINARY TEAM 
PAIN MANAGEMENT TEAM
Figure 1 Foot health screening pathway for people with RA foot‐related problems. This ﬁgure is available in colour online at
wileyonlinelibrary.com
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practice, an initial foot assessment and screening
should be carried out for all patients at the ﬁrst point
of contact with a podiatrist.
The management of speciﬁc foot problems (callus,
nail pathology, ulceration) and the use of speciﬁc
interventions (foot orthoses, footwear, patient educa-
tion, steroid injection therapy) are detailed and
standards in relation to each are provided within the
guidelines. As it was acknowledged by the NWCEG
that some foot problems are ideally managed through
collaboration with other members of the rheumatology
MDT, the guidelines also make recommendations
for referral and collaboration with other members of
the MDT.
The following are examples of the essential stan-
dards of assessment, management and collaboration.
However, readers should access the full guidelines for
the details and supporting information for all the
guideline standards.Assessment and management of
foot problems
All patients should be evaluated at the initial
assessment for the need for foot orthoses, footwear
advice and, where necessary, therapeutic footwear. The
use of foot orthoses and therapeutic footwear are
advocated by NICE (2010) and there is some evidence
that supports the use of therapeutic footwear for
reducing pain and improving mobility (Williams et al.,
2007) in those with established foot deformity.
In the case of early disease, feet should be assessed
for evidence of abnormal foot function within
18 months from onset of symptoms, before tarsal
erosions occur (Woodburn et al., 2002a). Functional
foot orthoses should be provided as soon as possible
following diagnosis, in order to reduce pain, improve
function and maintain alignment of the architecture of
the foot (Woodburn et al., 2002b).
Steroid injection therapy should be considered for
targeting localized, inﬂamed joints when the general
disease is controlled, but only in the absence of
infection (Ward et al., 2008). However, any associated
structural deformity should be managed with foot
orthoses in conjunction with steroid injection therapy
(Helliwell et al., 2006).
Callus over the plantar metatarsal area should be
assessed in relation to symptoms and causative factorsMusculoskelet. Care (2011) © 2011 John Wiley & Sons, Ltd.before debridement is considered. According to Davys
et al. (2005), debridement of callus over the plantar
metatarsal areas should be carried out with caution,
particularly over prominences such as those caused by
subluxation of the metatarso‐phalangeal joints, where it
may be considered to have a protective role. If callus is
removed, pressure‐relieving insoles or foot orthoses
should be provided (Davys et al., 2005), in order to
protect the foot from the risk of ulceration. Other
problems involving the skin are fungal infections, which
can also infect the nails. Fungal infections should be
investigated and treated, as they can lead to ulceration
and secondary bacterial infection (Jones, 1997).
Although there is no direct evidence of its beneﬁts,
there was a consensus from the group members that
patient education should be delivered as an essential
component of foot health and general health
management.Referral and collaboration
It was agreed through consensus in the group that
those patients with severe symptoms and/or complica-
tions, plus those with medical management that puts
them at risk of the serious consequences of foot
infections, should be managed by a specialist podia-
trist. Specialist podiatrists mostly work within the
rheumatology MDT or, if not, have clear and deﬁned
referral pathways for urgent problems that need to be
seen by the rheumatologist. However, some services do
not have specialist podiatrists, with many of their
patients being seen by a generalist podiatrist or by a
private practitioner (Williams and Bowden, 2004). It
was felt, therefore, that these practitioners should have
clear guidance as to when to refer to a rheumatologist
or other members of the MDT in order to protect the
patient from the severe consequences of foot infections
and ulceration.
A patient's rheumatologist or rheumatology nurse
must be contacted as a matter of urgency if patients who
are being managed with biologic therapy develop foot
ulceration and infection (Otter et al., 2004). Optimum
ulcer management for any patient can only be achieved
by a holistic and integrated MDT approach (Firth et al.,
2008). Further, there was consensus agreement that
advice should be taken from the patient's rheumatol-
ogist on the management of infected ingrown nails or if
there is a need for nail surgery, particularly if the
patient's medical management is with biologic therapy.
Guidelines for RA‐Related Foot Problems Williams et al.Other reasons for urgent collaboration include tendon
ruptures and septic arthritis, which require immediate
referral for both medical and surgical management
(Helliwell et al., 2006).
Foot health measurement
The use of foot health measurement tools, such the
Foot Impact Scale (Helliwell et al., 2005) or the Salford
Arthritis Foot Evaluation instrument (Walmsley,
2010), are considered as being a desirable adjunct to
clinical practice in order to evaluate the impact of foot
problems on the individual, but also to provide
evidence for the level of effectiveness of interventions.
Further to these measurement tools, the use of
musculoskeletal ultrasound is considered a useful
method of monitoring foot health, as well as its role
in the assessment and diagnosis of speciﬁc foot and
ankle pathology (Bowen, 2003).Discussion
The aim of these guidelines was to provide all
podiatrists and other foot health providers with
pragmatic clinical recommendations for the manage-
ment of RA‐related foot and ankle problems.
The authors acknowledge that there were limitations
to the approach taken to guideline development, in that
it was not based on a systematic review of the literature
and there was no meta‐analysis of data from the
available evidence. However, a pragmatic approach was
taken, whereby the available evidence was synthesized
with the clinical expertise of the members of the
NWCEG. This approach ensured that the guidelines
were relevant and applicable to current practice as ‘best
practice’, based on the available evidence from the
literature and consensus expert opinion. It was also an
iterative process in which ‘expert’ external reviewers
contributed to the ﬁnal document.
Future work will involve the revision of the guidelines
biannually, in order to embrace the emerging research
on foot and ankle management in people with RA.
Additionally, the NWCEG is developing an audit tool,
so that the standards can be mapped against clinical
practice.Conclusion
These guidelines provide both the essential and ‘gold
standard’ aspects of managing people with RA‐relatedfoot problems, in order to maintain and improve their
foot health, mobility and participation in life activities
and occupations.Acknowledgements
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